SynthesisFrontiers in nutrition2026
Efficacy and safety of probiotics in the treatment of iron deficiency anemia in Chinese children: a systematic review and meta-analysis.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This meta-analysis, combined with trial sequential analysis (TSA), aimed to evaluate the effects of probiotics on hematologic parameters and iron-regulation biomarkers in Chinese children with iron deficiency anemia (IDA). Methods: Ten electronic databases were systematically searched for eligible studies published up to April 30, 2026. Meta-analyses were conducted using RevMan (version 5.3), and TSA was performed with TSA software (version 0.9.5.10 beta). Dichotomous and continuous outcomes were pooled as risk ratios (RRs) and mean differences (MDs), respectively. Publication bias was assessed using Egger's and Harbord's tests. Results: Twelve randomized controlled trials involving 1,342 children with IDA were included. In terms of efficacy, probiotics significantly increased hemoglobin (Hb) (MD 8.64 g/L, 95% CI 6.77-10.52), red blood cell (MD 0.47 × 10 Conclusion: Probiotics may improve anemia-related parameters and iron metabolism in Chinese children with IDA. However, the pooled increase in Hb remains below the minimal clinically important difference, and evidence on total adverse events remains inconclusive. Therefore, probiotics should be considered as an adjunct to oral iron supplementation rather than a standalone intervention. These findings should be interpreted with caution due to potential biases and the inclusion of only Chinese children.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.